Annual Operating Profit
-$86.46 M
+$6.37 M+6.86%
December 31, 2023
Summary
- As of February 7, 2025, BDTX annual operating income is -$86.46 million, with the most recent change of +$6.37 million (+6.86%) on December 31, 2023.
- During the last 3 years, BDTX annual operating profit has fallen by -$16.89 million (-24.28%).
- BDTX annual operating profit is now -1999.05% below its all-time high of -$4.12 million, reached on December 31, 2017.
Performance
BDTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$18.13 M
+$4.00 M+18.08%
September 30, 2024
Summary
- As of February 7, 2025, BDTX quarterly operating income is -$18.13 million, with the most recent change of +$4.00 million (+18.08%) on September 30, 2024.
- Over the past year, BDTX quarterly operating profit has increased by +$5.88 million (+24.50%).
- BDTX quarterly operating profit is now -495.21% below its all-time high of -$3.05 million, reached on December 31, 2018.
Performance
BDTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$81.36 M
+$5.88 M+6.74%
September 30, 2024
Summary
- As of February 7, 2025, BDTX TTM operating income is -$81.36 million, with the most recent change of +$5.88 million (+6.74%) on September 30, 2024.
- Over the past year, BDTX TTM operating profit has increased by +$6.10 million (+6.97%).
- BDTX TTM operating profit is now -2571.08% below its all-time high of -$3.05 million, reached on December 31, 2018.
Performance
BDTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
BDTX Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +6.9% | +24.5% | +7.0% |
3 y3 years | -24.3% | +48.7% | +34.4% |
5 y5 years | -871.0% | -122.5% | -177.4% |
BDTX Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +31.9% | at high | +30.5% | at high | +35.9% |
5 y | 5-year | -194.8% | +31.9% | -75.3% | +48.7% | -177.4% | +35.9% |
alltime | all time | -1999.0% | +31.9% | -495.2% | +48.7% | -2571.1% | +35.9% |
Black Diamond Therapeutics Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$18.13 M(-18.1%) | -$81.36 M(-6.7%) |
Jun 2024 | - | -$22.13 M(+9.3%) | -$87.24 M(+2.5%) |
Mar 2024 | - | -$20.25 M(-2.9%) | -$85.14 M(-1.5%) |
Dec 2023 | -$86.46 M(-6.9%) | -$20.86 M(-13.1%) | -$86.46 M(-1.1%) |
Sep 2023 | - | -$24.01 M(+19.9%) | -$87.46 M(+2.2%) |
Jun 2023 | - | -$20.03 M(-7.1%) | -$85.57 M(-3.5%) |
Mar 2023 | - | -$21.56 M(-1.3%) | -$88.71 M(-4.4%) |
Dec 2022 | -$92.83 M(-26.8%) | -$21.85 M(-1.2%) | -$92.83 M(-4.4%) |
Sep 2022 | - | -$22.12 M(-4.5%) | -$97.06 M(-12.0%) |
Jun 2022 | - | -$23.17 M(-9.8%) | -$110.30 M(-9.5%) |
Mar 2022 | - | -$25.68 M(-1.5%) | -$121.84 M(-4.0%) |
Dec 2021 | -$126.87 M | -$26.08 M(-26.3%) | -$126.87 M(+2.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | -$35.36 M(+1.9%) | -$123.97 M(+15.8%) |
Jun 2021 | - | -$34.72 M(+13.0%) | -$107.09 M(+22.5%) |
Mar 2021 | - | -$30.71 M(+32.5%) | -$87.40 M(+25.6%) |
Dec 2020 | -$69.57 M(+137.2%) | -$23.18 M(+25.4%) | -$69.57 M(+22.6%) |
Sep 2020 | - | -$18.48 M(+23.0%) | -$56.73 M(+22.3%) |
Jun 2020 | - | -$15.03 M(+16.7%) | -$46.40 M(+20.9%) |
Mar 2020 | - | -$12.88 M(+24.5%) | -$38.37 M(+30.8%) |
Dec 2019 | -$29.33 M(+229.4%) | -$10.34 M(+27.0%) | -$29.33 M(+33.1%) |
Sep 2019 | - | -$8.15 M(+16.4%) | -$22.03 M(+58.7%) |
Jun 2019 | - | -$7.00 M(+82.2%) | -$13.89 M(+101.6%) |
Mar 2019 | - | -$3.84 M(+26.1%) | -$6.89 M(+126.1%) |
Dec 2018 | -$8.90 M(+116.2%) | -$3.05 M | -$3.05 M |
Dec 2017 | -$4.12 M | - | - |
FAQ
- What is Black Diamond Therapeutics annual operating income?
- What is the all time high annual operating profit for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual operating profit year-on-year change?
- What is Black Diamond Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly operating profit year-on-year change?
- What is Black Diamond Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics TTM operating profit year-on-year change?
What is Black Diamond Therapeutics annual operating income?
The current annual operating profit of BDTX is -$86.46 M
What is the all time high annual operating profit for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual operating income is -$4.12 M
What is Black Diamond Therapeutics annual operating profit year-on-year change?
Over the past year, BDTX annual operating income has changed by +$6.37 M (+6.86%)
What is Black Diamond Therapeutics quarterly operating income?
The current quarterly operating profit of BDTX is -$18.13 M
What is the all time high quarterly operating profit for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly operating income is -$3.05 M
What is Black Diamond Therapeutics quarterly operating profit year-on-year change?
Over the past year, BDTX quarterly operating income has changed by +$5.88 M (+24.50%)
What is Black Diamond Therapeutics TTM operating income?
The current TTM operating profit of BDTX is -$81.36 M
What is the all time high TTM operating profit for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high TTM operating income is -$3.05 M
What is Black Diamond Therapeutics TTM operating profit year-on-year change?
Over the past year, BDTX TTM operating income has changed by +$6.10 M (+6.97%)